Retroviral protease inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546165, 546153, 514311, 514312, 514313, 514314, C07D21548, A61K 3147

Patent

active

055084079

ABSTRACT:
The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of their use.

REFERENCES:
Roberts, N. A. et al, Science, 248, 358-361 (1990).
Tam, T. F. et al., Journal of Medicinal Chemistry, 35(7), 1318-1320 (3 Apr. 1992).
Young, S. G., et al., Journal of Medicinal Chemistry, 35(10), 1702-1709 (15 May 1992).
Huff, J. R., Journal of Medicinal Chemistry, 34(8), 2305-2314 (Aug. 1991).
Snieckus, Chemical Reviews, 90, 879-933 (1990).
Beak, et al., Tetrahedron, 39, 1983-1989 (1983).
Nahm and Weinreb, Tetrahedron Letters, 22, 3815-3818 (1981).
Fehrentz and Castro, Synthesis, No. 8, 676-678 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-326207

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.